
Kanoria Chemicals (KANORICHEM) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
4.5B
Gross Profit
1.3B
29.13%
Operating Income
-3.7M
-0.08%
Net Income
-137.8M
-3.04%
EPS (Diluted)
₹-1.79
Balance Sheet Metrics
Total Assets
15.0B
Total Liabilities
9.9B
Shareholders Equity
5.1B
Debt to Equity
1.94
Cash Flow Metrics
Revenue & Profitability Trend
Kanoria Chemicals Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 15.1B | 14.6B | 15.7B | 13.6B | 10.9B |
Cost of Goods Sold | 11.0B | 10.3B | 11.5B | 9.8B | 7.5B |
Gross Profit | 4.1B | 4.3B | 4.2B | 3.8B | 3.4B |
Gross Margin % | 27.2% | 29.3% | 26.6% | 27.7% | 31.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 427.1M | 364.6M | 327.3M | 278.0M | 204.9M |
Other Operating Expenses | 1.1B | 1.1B | 1.0B | 862.0M | 633.8M |
Total Operating Expenses | 1.6B | 1.4B | 1.3B | 1.1B | 838.7M |
Operating Income | -303.1M | 5.2M | 137.4M | 126.0M | 359.1M |
Operating Margin % | -2.0% | 0.0% | 0.9% | 0.9% | 3.3% |
Non-Operating Items | |||||
Interest Income | 3.4M | 2.9M | 1.8M | 4.0M | 14.1M |
Interest Expense | 408.2M | 377.2M | 313.1M | 198.6M | 296.7M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -972.5M | -359.6M | -122.1M | 131.3M | 114.2M |
Income Tax | 117.9M | 193.1M | 6.7M | 109.0M | -45.6M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 83.0% | -40.0% |
Net Income | -1.1B | -552.8M | -128.8M | 22.3M | 159.9M |
Net Margin % | -7.1% | -3.8% | -0.8% | 0.2% | 1.5% |
Key Metrics | |||||
EBITDA | 44.5M | 519.9M | 692.5M | 864.2M | 1.1B |
EPS (Basic) | ₹-19.13 | ₹-8.79 | ₹-2.01 | ₹1.56 | ₹3.32 |
EPS (Diluted) | ₹-19.13 | ₹-8.79 | ₹-2.01 | ₹1.56 | ₹3.32 |
Basic Shares Outstanding | 43693333 | 43693333 | 43693333 | 43693333 | 43693333 |
Diluted Shares Outstanding | 43693333 | 43693333 | 43693333 | 43693333 | 43693333 |
Income Statement Trend
Kanoria Chemicals Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 80.9M | 112.2M | 188.6M | 188.8M | 319.6M |
Short-term Investments | 25.8M | 45.2M | 85.8M | 125.9M | 28.5M |
Accounts Receivable | 2.4B | 1.9B | 2.0B | 1.7B | 2.0B |
Inventory | 2.5B | 2.9B | 2.8B | 2.5B | 1.7B |
Other Current Assets | 230.0K | 505.4M | 520.4M | 322.6M | 344.4M |
Total Current Assets | 5.7B | 5.6B | 5.7B | 5.1B | 4.6B |
Non-Current Assets | |||||
Property, Plant & Equipment | 8.5B | 8.1B | 8.4B | 8.3B | 8.3B |
Goodwill | 175.8M | 749.1M | 745.7M | 725.7M | 728.6M |
Intangible Assets | 56.9M | 44.1M | 43.8M | 33.3M | 42.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 56.3M | 141.4M | 34.8M | 45.3M | 31.1M |
Total Non-Current Assets | 9.3B | 9.3B | 9.1B | 9.0B | 9.0B |
Total Assets | 15.0B | 14.9B | 14.8B | 14.0B | 13.6B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 2.3B | 2.2B | 2.3B | 2.1B | 1.5B |
Short-term Debt | 2.5B | 2.1B | 1.9B | 1.3B | 1.5B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 467.5M | 247.3M | 191.4M | 153.6M | 239.9M |
Total Current Liabilities | 5.7B | 5.1B | 5.1B | 4.1B | 3.8B |
Non-Current Liabilities | |||||
Long-term Debt | 3.4B | 3.0B | 3.2B | 3.5B | 3.5B |
Deferred Tax Liabilities | 585.6M | 517.9M | 334.9M | 349.4M | 324.0M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 4.2B | 3.6B | 3.7B | 3.9B | 3.9B |
Total Liabilities | 9.9B | 8.7B | 8.7B | 8.0B | 7.7B |
Equity | |||||
Common Stock | 218.5M | 218.5M | 218.5M | 218.5M | 218.5M |
Retained Earnings | 3.7B | 4.6B | 4.8B | 5.0B | 5.0B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 5.1B | 6.2B | 6.1B | 6.0B | 6.0B |
Key Metrics | |||||
Total Debt | 6.0B | 5.1B | 5.1B | 4.7B | 4.9B |
Working Capital | -49.7M | 538.5M | 633.9M | 971.1M | 839.6M |
Balance Sheet Composition
Kanoria Chemicals Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -972.5M | -335.4M | -122.1M | 131.3M | 152.1M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -112.1M | -52.9M | -668.1M | -583.9M | -416.2M |
Operating Cash Flow | -336.8M | 58.8M | -442.7M | -178.2M | 45.4M |
Investing Activities | |||||
Capital Expenditures | -786.9M | -742.9M | -377.9M | -420.2M | -235.2M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -20.0K | -20.0M | -200.0K | -34.2M | -5.1M |
Investment Sales | 104.8M | 252.1M | 49.0M | 17.8M | 106.6M |
Investing Cash Flow | -654.4M | -506.5M | -293.9M | -436.5M | -133.8M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | -43.7M | - | - |
Debt Issuance | 1.1B | - | 323.6M | - | - |
Debt Repayment | -459.3M | -8.8M | - | -300.3M | -494.5M |
Financing Cash Flow | 873.6M | 518.7M | 322.0M | -300.3M | -494.5M |
Free Cash Flow | -800.1M | -432.2M | -317.6M | 402.2M | 548.2M |
Net Change in Cash | -117.6M | 71.0M | -414.6M | -915.0M | -582.8M |
Cash Flow Trend
Kanoria Chemicals Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
45.64
Price to Book
0.68
Price to Sales
0.22
PEG Ratio
-0.86
Profitability Ratios
Profit Margin
-4.66%
Operating Margin
-0.08%
Return on Equity
-16.38%
Return on Assets
-5.58%
Financial Health
Current Ratio
0.99
Debt to Equity
116.61
Beta
0.00
Per Share Data
EPS (TTM)
₹-17.08
Book Value per Share
₹119.11
Revenue per Share
₹367.44
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
kanorichem | 3.5B | 45.64 | 0.68 | -16.38% | -4.66% | 116.61 |
Deepak Nitrite | 250.4B | 41.19 | 4.64 | 11.85% | 7.58% | 23.36 |
Navin Fluorine | 236.7B | 64.78 | 8.73 | 10.99% | 13.90% | 55.85 |
Styrenix Performance | 41.7B | 18.30 | 3.54 | 20.14% | 7.00% | 34.02 |
Gujarat Alkalies | 40.7B | 70.12 | 0.67 | -1.15% | -0.82% | 9.30 |
Foseco India Limited | 34.4B | 41.71 | 9.26 | 24.30% | 14.05% | 0.42 |
Financial data is updated regularly. All figures are in the company's reporting currency.